Palvella Therapeutics Inc... (PVLA)
NASDAQ: PVLA
· Real-Time Price · USD
47.12
1.02 (2.21%)
At close: Aug 15, 2025, 3:59 PM
48.00
1.88%
After-hours: Aug 15, 2025, 05:20 PM EDT
Palvella Therapeutics Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 53K | 1.35M | 20.87M | 40.93M | 42.81M | 47.36M | 33.21M | 16.85M | 25.9M | 28.5M | 27.19M | 26.77M | 31.42M | 24.85M | 23.73M | 31.7M |
Cost of Revenue | n/a | -30K | -30K | 709K | 1.43M | 2.04M | 2.62M | 2.65M | 2.5M | 2.77M | 2.77M | 2M | 1.43M | 588K | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | 18.78M | 38.11M | 38.11M | 43.37M | 29.19M | 12.98M | 23.13M | 25.73M | 21.13M | 18M | 7.86M | n/a | n/a | n/a |
Operating Income | -15.18M | -16.94M | -21.55M | -15.33M | -9.09M | -11.87M | -10.91M | -26.16M | -40.56M | -43.47M | -42.95M | -49.8M | -54.23M | -51.83M | -53.24M | -47.23M | -35.12M |
Interest Income | 1.12M | 1.21M | 911K | 1.29M | 1.58M | 1.85M | 1.75M | 1.44M | 1.08M | 724K | 373K | 136K | 7K | 10K | 18K | 69K | 195K |
Pretax Income | -24.13M | -17.2M | 23.17M | 15.3M | 22.87M | 18.69M | -21.59M | -20.57M | -34.89M | -33.28M | -34.71M | -41.51M | -46.67M | -45.74M | -50.44M | -48.19M | -37.64M |
Net Income | -24.13M | -17.2M | -13.6M | -21.46M | -13.9M | -18.07M | -21.59M | -20.57M | -34.89M | -33.28M | -34.71M | -41.51M | -46.67M | -45.74M | -50.61M | -48.35M | -37.8M |
Selling & General & Admin | 14.94M | 11.58M | 10.11M | 12.63M | 12.9M | 13.05M | 14.7M | 12.54M | 12.93M | 16.39M | 16.52M | 16.73M | 16.91M | 16.68M | 16.33M | 16.55M | 16.85M |
Research & Development | 9.5M | 5.36M | 5.74M | 15.78M | 28.6M | 31.23M | 39.59M | 42.81M | 40.61M | 50.21M | 52.16M | 57.66M | 61.48M | 64.2M | 59.38M | 52.12M | 47.74M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 24.43M | 16.94M | 15.85M | 28.41M | 41.5M | 56.62M | 66.62M | 67.69M | 65.88M | 66.61M | 68.68M | 74.4M | 78.39M | 80.88M | 75.71M | 68.67M | 64.59M |
Interest Expense | -139K | 2.02M | 805K | 805K | 805K | 2.58M | 2.58M | 2.58M | 2.58M | 3K | 9K | 9K | 9K | 6K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.18M | 16.94M | 15.85M | 29.15M | 42.97M | 45.75M | 56.33M | 22.36M | -11.66M | 2.24M | 4.32M | -1.21M | -5.23M | -44.37M | -78.09M | -70.96M | -66.82M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 164K | 164K | 164K |
Shares Outstanding (Basic) | 11.05M | 2.23M | 1.32M | 1.3M | 1.27M | 1.24M | 1.24M | 1.09M | 11.22M | 930.74K | 929.96K | 926.56K | 921.39K | 902.78K | 846.63K | 773.81K | 703.71K |
Shares Outstanding (Diluted) | 11.05M | 2.23M | 1.32M | 1.3M | 1.27M | 1.24M | 1.24M | 1.1M | 11.22M | 930.74K | 929.96K | 926.56K | 921.39K | 902.78K | 846.63K | 773.81K | 703.71K |
EPS (Basic) | -9.49 | -10.63 | -10.66 | -17.17 | -10.78 | -9.4 | -14.39 | -16.16 | -30.95 | -35.87 | -37.73 | -46.79 | -55.66 | -56.05 | -66.06 | -67.56 | -55.09 |
EPS (Diluted) | -9.49 | -10.63 | -10.66 | -17.17 | -10.79 | -9.41 | -14.4 | -16.17 | -30.95 | -35.87 | -37.73 | -46.79 | -55.66 | -56.05 | -66.06 | -67.56 | -55.09 |
EBITDA | -13.45M | -15.18M | -12.79M | -19.92M | -11.63M | -14.03M | -16.96M | -15.91M | -30.38M | -30.5M | -31.93M | -38.91M | -44.05M | -43.36M | -48.05M | -45.89M | -35.41M |
EBIT | -13.45M | -15.18M | -12.79M | -20.66M | -13.09M | -15.49M | -19.01M | -18M | -32.31M | -33.27M | -34.7M | -41.5M | -46.66M | -45.73M | -50.44M | -48.19M | -37.64M |
Depreciation & Amortization | n/a | n/a | n/a | 739K | 1.46M | 2.04M | 2.62M | 2.65M | 2.5M | 2.77M | 2.77M | 2.59M | 2.61M | 2.37M | 2.39M | 2.3M | 2.23M |